Home / Share Price Target / Hcg
HCG Share Price Target 2024, 2025, 2026 to 2039 With Charts
HealthCare Global Enterprises Limited | |||
 | Symbol: HCG | ||
| Price: ₹468.5 | |||
| Exchange: NSE | |||
| Healthcare -> Medical Care Facilities | |||
Show Table of Contents
Table of Contents
- 1: HCG Brief Company Overview
- 1.1: HealthCare Global Enterprises Limited
- 1.2: HCG Financial Performance
- 1.2.1: Is HCG A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: HCG Share Price Target For 2024
- 2.1.1: HCG Share Price Target Table For 2024
- 2.1.2: Summary: HCG Share Price Prediction For 2024
- 2.2: HCG Share Price Target For 2025
- 2.2.1: HCG Share Price Target Table For 2025
- 2.2.2: Summary: HCG Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: HCG Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: HCG Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: HCG Past Performance
HCG Brief Company Overview
HealthCare Global Enterprises Limited
HealthCare Global Enterprises Limited, established in 1989, is a leading healthcare service provider focused on cancer and fertility. Headquartered in Bengaluru, India, the company has a strong presence in the industry.
Key Products and Services:
- Cancer diagnosis and treatment through radiation therapy, medical oncology, and surgery
- Fertility treatment, assisted reproduction, gynecological endoscopy, and fertility preservation
- Multi-specialty hospital services under the HCG brand
- Medical diagnostic services
Reputation and Commitment:
HealthCare Global has earned a strong reputation for providing high-quality healthcare services. The company is committed to delivering compassionate and effective care to its patients.
Diverse Product Range:
The company's diverse product range caters to a wide range of healthcare needs. Its services include cancer treatment, fertility treatments, and multi-specialty hospital services.
HCG Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 6,517.73 Crore | Market valuation of HCG's shares. |
| Revenue (TTM) | 1,977.02 Crore | Total revenue generated by HCG over the past twelve months. |
| Net Income (TTM) | +52.61 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 8.35% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 2.66% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +14.09% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +58.7% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 147.3 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1,274.37 Crore | Sum of HCG's current & long-term financial obligations. |
| Total Cash | 303.07 Crore | Total amount of liquid funds available to HCG. |
| Beta | 0.28 | Beta is less than 1 indicating that the HCG's price is less volatile than the market. |
Is HCG A Good Buy For Long Term?
HCG, a mid-cap stock with a market capitalization of ₹6,552.58 crore, shows strong recent performance (33.12% return in the last 3 months, 188.84% over 3 years). However, a significant debt of ₹1,557.94 crore (Q2 2024-25) against a cash balance of ₹290.14 crore raises concerns. While revenue growth is positive (13.7% QoQ), the profit margin is low at 2.79%. Considering the high debt and modest profitability, HCG is an average buy for the long term, requiring close monitoring of debt reduction and profit margin improvement.
To predict the HCG's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
HCG Share Price Target For 2024
The line chart displays the monthly closing prices of HCG with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for HCG shares in 2024, see the table below.
HCG Share Price Target Table For 2024
| HCG's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 482.31 (+2.94%) | Fibonacci Extension Level 199% |
| 2024 Target 2 | 476.00 (+1.6%) | Price Action: 19 Nov 2024 High |
| 2024 Target 1 | 470.67 (+0.46%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 468.50 | HCG's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 467.83 (-0.15%) | Price Action: Chart |
| Stop Loss 2 | 462.89 (-1.2%) | Price Action: 19 Nov 2024 Low |
| Stop Loss 3 | 456.40 (-2.59%) | Fibonacci Retracement Extended 82.6% |
Summary: HCG Share Price Prediction For 2024
In summary, HCG has surged by ₹103.00, achieving a notable +28.18% increase from 1st January 2024 to 21 Nov 2024. Our analysis of HCG for 2024 predicts an additional rise of 0.46% to 2.94% by the end of 2024 with three potential targets T1: 470.67, T2: 476.00, T3: 482.31. Stop Loss at SL1: 467.83, SL2: 462.89, SL3: 456.40.
HCG has a 52-week high of ₹519.50, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹314.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for HCG.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
HCG Share Price Target For 2025
The line chart displays the monthly closing prices of HCG with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for HCG shares in 2025, see the table below.
HCG Share Price Target Table For 2025
| HCG's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 587.51 (+25.4%) | Fibonacci Extension Level 171.8% |
| 2025 Target 2 | 577.54 (+23.27%) | Price Action: Chart |
| 2025 Target 1 | 571.82 (+22.05%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 468.50 | HCG's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 444.50 (-5.13%) | Price Action: 17 Oct 2024 High |
| Stop Loss 2 | 435.79 (-6.99%) | Price Action: 16 Oct 2024 Low |
| Stop Loss 3 | 430.79 (-8.05%) | Price Action: 22 Oct 2024 High |
Summary: HCG Share Price Prediction For 2025
In summary, HCG has surged by ₹103.00, achieving a notable +28.18% increase from 1st January 2024 to 21 Nov 2024. Our analysis of HCG for 2025 predicts an additional rise of 22.05% to 25.4% by the end of 2025 with three potential targets T1: 571.82, T2: 577.54, T3: 587.51. Stop Loss at SL1: 444.50, SL2: 435.79, SL3: 430.79.
HCG has a All-Time high of ₹519.50, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹314.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for HCG, we have created a specific page for that check here: HCG Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
HCG Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of HCG share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 13.31% over the next 15 years.
For complete year by year HCG long term share price target from 2024, 2025 to 2039 check the below table.
HCG Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | HCG Target | YoY Change % |
|---|---|---|
| 2024 | ₹468.5 | [Current Price] |
| 2024 | ₹470.44 | 0.41% |
| 2025 | ₹634.79 | 34.93% |
| 2026 | ₹736.69 | 16.05% |
| 2027 | ₹951.01 | 29.09% |
| 2028 | ₹1,066.54 | 12.14% |
| 2029 | ₹1,225.48 | 14.9% |
| 2030 | ₹1,406.03 | 14.73% |
| 2031 | ₹1,456.77 | 3.6% |
| 2032 | ₹1,728.58 | 18.65% |
| 2033 | ₹1,816.01 | 5.05% |
| 2034 | ₹1,980.53 | 9.05% |
| 2035 | ₹2,177.28 | 9.93% |
| 2036 | ₹2,176.84 | -0.03% |
| 2037 | ₹2,506.14 | 15.12% |
| 2038 | ₹2,565.46 | 2.36% |
| 2039 | ₹2,706.16 | 5.48% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
HCG Past Performance
- In 2016, HCG opening price was ₹178.1
- As of Thu 21 Nov 2024 the price stands at ₹468.5.
- This represents a Compound Annual Growth Rate (CAGR) of 11.35%.
- In 8 years, an investment of 10,000 would have become ₹26,305.44.
As we wrap up, we hope you like our study on HCG share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
